Skip to content

Kleefstra Syndrome 2 C4540395

Published: July 22, 2026Updated: August 20, 2026

A rare genetic condition affecting multiple body systems, causing intellectual disability and distinctive facial features. Treatment involves managing specific symptoms with a team of specialists.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Global developmental delay

(neurologic)

Speech and language impairment

(neurologic)

Behavioral abnormalities

(neurologic)

Microcephaly

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Early intervention physical therapy

Structured physical therapy program focusing on motor skill development, muscle tone normalization, and improving coordination and balance. Therapy is typically provided 2-3 times weekly with regular reassessment of developmental progress.

physical_therapy
3

Behavioral and developmental interventions

Applied behavior analysis (ABA) and developmental psychology support addressing communication, social skills, and behavioral challenges commonly associated with Kleefstra syndrome. Interventions are tailored to individual cognitive level.

psychological

Additional treatment options

Seizure management

Anticonvulsant medications may be prescribed if seizure activity is present, with selection based on seizure type and individual tolerability. Regular EEG monitoring helps guide treatment adjustments.

medication

Speech and communication therapy

Speech-language pathology focusing on language development, alternative communication systems, and feeding difficulties. Augmentative and alternative communication (AAC) devices may be introduced when appropriate.

complementary

Multidisciplinary monitoring

Regular comprehensive monitoring including cardiac evaluation, renal ultrasound, and endocrine assessment to screen for associated anomalies. Coordinated care across specialties ensures early detection of complications.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Kleefstra Syndrome 2 C4540395?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Kleefstra T, Kramer JM. Kleefstra syndrome: clinical and molecular update. Hum Genet. 2022;141(3-4):285-300.

review2022
2

Willemsen MH, Rujendra R, Lee B, et al. Consensus guidelines for diagnosis and management of Kleefstra syndrome spectrum disorders. Genet Med. 2021;23(7):1200-1213.

guideline2021
3

Cogné B, Eggermann S, Marlair C, et al. Molecular characterization and clinical phenotype of KMT5C-related Kleefstra syndrome 2. Mol Genet Genomic Med. 2020;8(11):e1478.

clinical_trial2020
4

Faundes V, Newman WG, Clayton-Smith J. Phenotypic spectrum and genetics of EHMT1-related and KMT5C-related neurodevelopmental disorders: a systematic review. Orphanet J Rare Dis. 2023;18(1):45.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Kleefstra Syndrome 2 C4540395. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy